Heron Therapeutics, Inc. (NASDAQ:HRTX) Q1 2024 Earnings Conference Call May 7, 2024 8:30 AM ET

Company Participants

Craig Collard - Chief Executive Officer
Ira Duarte - Executive Vice President and Chief Financial Officer
William Forbes - Executive Vice President, Chief Development Officer
Kevin Warner - SVP of Medical Affairs strategy engagements
David Barozzino - Vice President of Sales, Acute Care

Conference Call Participants

Serge Berlanger - Needham
Carl Byrnes - Northland Capital Markets
Tim Chiang - Capital One

Operator

Thank you for standing by. My name is Alex and I will be your conference operator today. At this time, I would like to welcome everyone to the Heron Therapeutics Q1 2024 Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session. [Operator Instructions].

I would now like to turn the call over to Melissa Dorel [ph], Executive Director, Legal. Please go ahead.

Unidentified Company Representative

Thank you, operator, and good morning everyone. Thank you for joining us on the Heron Therapeutics conference call this afternoon to discuss the company's financial results for the quarter ended March 31, 2024. With me today from Heron are Craig Collard, Chief Executive Officer; Ira Duarte, Executive Vice President, Chief Financial Officer; Bill Forbes, Executive Vice President, Chief Development Officer. For those of you participating via conference call, slides are made available via webcast and can also be accessed via the Investor Relations page of our website following the conclusion of today's call.

Before we begin, let me quickly remind you that during the course of this conference call, the company will make forward-looking statements. We caution you that any statement that is not a statement of historical fact is a forward-looking statement. This includes remarks about the company's projections, expectations, plans, beliefs and future performance, all of which constitute forward-looking statements for the purposes of the safe harbor provision under the Private Securities Litigation Reform Act of 1995. These statements are based on judgment and analysis as of the date of this conference call and are subject to numerous important risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements.

The risks and uncertainties associated with the forward-looking statements made in this conference call and webcast are described in the safe harbor statement in today's press release and in Heron's public periodic filings with the SEC. Except as required by law, Heron assumes no obligation to update these forward-looking statements to reflect future events or actual outcomes and does not intend to do so.